Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

CFA Society Japan: Bram Wagner to guest lecture on ESG in pharma

Bram Wagner, Investment Engagement Officer at the Access to Medicine Foundation, has been invited to speak as a guest lecturer during a webinar, hosted by the CFA Society Japan in collaboration with the Nomura Research Institute.

Date

23 January 2024

DATE

23 January 2024

TIME

19:00-20:30 JST

FORMAT

Virtual

On 23 January 2024, the CFA Society Japan and the Nomura Reseach Institute, the largest economic research and consulting institute in Japan, will jointly host a webinar focusing on ESG in Pharma. 

Bram Wagner, Investment Engagement Officer at the Access to Medicine Foundation, will serve as a guest lecturer during the webinar, presenting a session on “Unveiling opportunities for investors in access to medicine”. Bram will discuss the Foundation’s work, the topic of access to medicine, as well as the Foundation’s investor engagement work.  

During his guest lecture, Bram will cover a range of key topics to help investment professionals understand some of the critical issues around ESG in pharma, including how investors play a pivotal role in steering change within the pharmaceutical landscape. 

Following Bram’s session, the Medicine Patent Pool’s (MPP’s) Parag Nimbolkar, Business Development Manager, In-licensing (Geneva), will present a session on the MPP’s work.  

Resource centre

Explore our research reports and publications
Event

Investor launch event for new analysis of major generics companies – Meeting Report

31 October 2023
Research

Investor Action on Antimicrobial Resistance progress report

21 November 2022
Research

STAT: Global investors must support pharma solidarity and collaboration in response to COVID-19

28 September 2020

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved